Holly Whitton

Biochemistry, Genetics and Molecular Biology · Life Sciences

10h-index3.0kcitations31works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ubiquitin and proteasome pathways(14), Protein Degradation and Inhibitors(13), Lymphoma Diagnosis and Treatment(5), CRISPR and Genetic Engineering(4), Chronic Lymphocytic Leukemia Research(4)

Publications31 total

Supplementary Table S1 - S3 from Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma
2023Open Access
Supplementary Figure S2 from Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma
2023Open Access
Supplementary Table S4 from Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma
2023Open Access
Supplementary Methods, Figure Legends, Table Legends from Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma
2023Open Access
Data from Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma
2023Open Access
Supplementary Figure S3 from Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma
2023Open Access
Supplementary Figure S5 from Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma
2023Open Access
Data from Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma
2023Open Access
Supplementary Figure S3 from Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma
2023Open Access
Supplementary Figure S4 from Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma
2023Open Access
Supplementary Figure S2 from Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma
2023Open Access
Supplementary Figure S5 from Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma
2023Open Access
Supplementary Table S1 - S3 from Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma
2023Open Access
Supplementary Figure S1 from Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma
2023Open Access
Supplementary Table S4 from Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma
2023Open Access
Supplementary Figure S1 from Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma
2023Open Access
Supplementary Figure S4 from Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma
2023Open Access
Supplementary Methods, Figure Legends, Table Legends from Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma
2023Open Access
Evaluation of Homology-Independent CRISPR-Cas9 Off-Target Assessment Methods
The CRISPR Journal·2020· 48 citedOpen Access
156 Discovery of TSC-100: A natural HA-1-specific TCR to treat leukemia following hematopoietic stem cell transplant therapy
Regular and Young Investigator Award Abstracts·2020Open Access
page 1 of 2Next →

Frequent Co-authors

Charles B. Epstein(24), B Bernstein(23), Yotam Drier(22), Robbyn Issner(21), Russell J.H. Ryan(20), Shawn Gillespie(20), Valentina Nardi(20), Aliyah R. Sohani(20), Ephraim P. Hochberg(20), Jasleen Kaur(18), M. Joel Cotton(16), Gavin MacBeath(5), Garrett S. Dunlap(4), Qikai Xu(4), Nancy Nabilsi(4), Candace R. Perullo(4), Alexander Cristofaro(4), Amy Virbasius(4), Kenneth J. Olivier(4), Matthew J. Cotton(4)